Viewing Study NCT05333458

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:14 AM
Ignite Modification Date: 2026-01-06 @ 8:05 AM
Study NCT ID: NCT05333458
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2022-04-15
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, The AXIOM Trial
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Alveolar Soft Part Sarcoma View
None Advanced Soft Tissue Sarcoma View
None Metastatic Alveolar Soft Part Sarcoma View
None Refractory Alveolar Soft Part Sarcoma View
None Unresectable Alveolar Soft Part Sarcoma View
Keywords: